FDG PET Imaging in Diagnosing Patients With Glioblastoma

EARLY_PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 28, 2016

Primary Completion Date

July 12, 2022

Study Completion Date

July 12, 2022

Conditions

Brain Glioblastoma

Interventions

PROCEDURE

Computed Tomography

Undergo PET/CT scans

RADIATION

Fludeoxyglucose F-18

Given IV

PROCEDURE

Magnetic Resonance Imaging

Undergo standard of care MRI

PROCEDURE

Positron Emission Tomography

Undergo PET/CT scans

Trial Locations (1)

M D Anderson Cancer Center, Houston

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

M.D. Anderson Cancer Center

OTHER

NCT02885272 - FDG PET Imaging in Diagnosing Patients With Glioblastoma | Biotech Hunter | Biotech Hunter